Topic: Pfizer Inc.
WASHINGTON (Reuters) - Pfizer's drug to help smokers quit, which has already been linked to psychiatric side effects, can lead to a small increase in heart problems in those who have cardiovascular disease, U.S. health regulators said on Thursday.The Food and Drug ...
NEW ORLEANS (Reuters) - Sophisticated devices and nonsurgical techniques look to be the wave of the future in the battle against heart disease as drugmakers produce fewer new medicines to fight the world's leading cause of death.Signs of the trend were evident ...
Rates of Heart Failure Hospitalization, All-Cause Hospitalization, and All-Cause Mortality also Significantly Reduced Download image. PFE) today announced results from the EMPHASIS-HF trial(1) showing a statistically significant reduction in risk of cardiovascular (CV) death or heart failure (HF) hospitalization for patients with ...
ApoA-1 Milano is a naturally occurring Clinically known as ETC-216, Pfizer has not moved trials forward, probably because the protein is complex and very expensive to produce and must be administered intravenous ly, thus limiting its application as compared to oral medications ...
Much of What Doctors Know and Do in Medicine is Flat-Out Wrong!. Pfizer drug manufacturer provides an example of profits before patient care and well-being. After a recent publication of a study indicating doctors were not aware of the results about an ...
Data from AVERROES Trial of Investigational Drug Apixaban Will Be Presented During a Hot Line Session at Upcoming European Society of Cardiology Meeting. Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer (NYSE: PFE) report that preliminary results from the Phase 3 AVERROES clinical ...
NEW YORK (Reuters) - Pfizer Inc said on Thursday it is halting recruitment of patients into a heart failure clinical study involving its drug Inspra because the study reached its main efficacy goal early.An independent committee monitoring the study found in an ...
Adding coronary artery calcium scores (CACS) to traditional risk factors for coronary heart disease (CHD) events significantly improves predictions of risk, and results in more individuals being placed in the highest and lowest risk categories, according to research published in the April ...
Phase III Data Published in The Lancet also Demonstrate Comparable Rates of Bleeding with Apixaban Versus Enoxaparin. In 2007, Pfizer and Bristol-Myers Squibb entered into a worldwide collaboration to develop and commercialize apixaban, an investigational oral anticoagulant discovered by Bristol-Myers Squibb being ...
Bristol-Myers Squibb Co. and Pfizer Inc. on Thursday said their blood thinner apixaban was more effective than Sanofi-Aventis' Lovenox in a late stage clinical trial.. The study compared the drugs' ability to reduce blood clots in the legs or lungs, also called ...
Photo Gallery
-
Pfizer Settlement
FBI Assistant Director of Criminal Investigative Division Kevin Perkins, right, looks on ...AP News - -
Pfizer CEO
Jeffrey Kindler, chairman and CEO of Pfizer, speaks at a news conference ...AP News - -
Pfizer to acquire Wyeth for $68 billion dollars
epa01614571 Jeffery B. Kindler, Chairman and CEO of Pfizer (L) speaks as ...ZUMA Press Inc -
From Around the Web
Video Gallery
-
Pfizer is Recalling Birth Control Pills
Pfizer Inc. is recalling about a million packages of two ...2012-02-01 -
Company Profile: Pfizer Inc.
The company is the world's largest research-based pharmaceuticals firm ...2010-04-08 -
Pfizer Considering Acquisition of Partner Icagen, ...
Drug giant Pfizer Inc (NYSE:PFE) said in a regulatory ...2011-06-27
